Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Original Article

Rescue therapy with adefovir in decompensated liver cirrhosis patients with lamivudine-resistant hepatitis B virus

Hyun Young Woo, Jong Young Choi, Seung Kew Yoon, Dong Jin Suh, Seung Woon Paik, Kwang Hyub Han, Soon Ho Um, Byung Ik Kim, Heon Ju Lee, Mong Cho, Chun Kyon Lee, Dong Joon Kim, Jae Seok Hwang

Clin Mol Hepatol. 2014;20(2):168-176. Published online June 30, 2014

DOI: https://doi.org/10.3350/cmh.2014.20.2.168

View: 8055 Download: 61 Web of Science: 4 Crossref: 2

3

Virologic response to adefovir dipivoxil monotherapy is not durable in HBeAg-positive, Lamivudine-resistant chronic hepatitis B patients

Hyun Wook Jung , Moon Seok Choi , Kap Hyun Kim , Sung Hyun Park , Keum Yeon Kwak , Joon Hyoek Lee , Kwang Cheol Koh , Seung Woon Paik , Byung Chul Yoo

Clin Mol Hepatol. 2009;15(1):52-58. Published online March 31, 2009

DOI: https://doi.org/10.3350/kjhep.2009.15.1.52

View: 4499 Download: 21

Efficacy and Safety of Adefovir Dipivoxil in Patients with Decompensated Liver Cirrhosis with Lamivudine Resistance Compared to Patients with Compensated Liver Disease

Won Moon, M.D., Moon Seok Choi, M.D., Yu Mi Moon, R.N., Seung Woon Paik, M.D., Joon Hyoek Lee, M.D., Kwang Cheol Koh, M.D., Byung Chul Yoo, M.D., Jong Chul Rhee, M.D. and Sang Goon Shim, M.D.

Clin Mol Hepatol. 2005;11(2):125-134. Published online January 1, 2000

View: 2242 Download: 16

2

Treatment of Chronic Hepatitis B ; Dose and Treatment Duration of Regimen

Young Oh Kweon

Clin Mol Hepatol. 2005;11(1):13-16. Published online January 1, 2000

View: 2392 Download: 13

Treatment of Chronic Hepatitis B ; Indication of Drug Therapy in Patients with Chronic Hepatitis B

Mong Cho

Clin Mol Hepatol. 2005;11(1):1-8. Published online January 1, 2000

View: 2685 Download: 17

1 |

Viewed By 5282	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 5221	MAFLD: How is it different from NAFLD?
Viewed By 5122	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 3841	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 3778	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 114	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 103	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 76	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 65	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
Cited By 52	MAFLD: How is it different from NAFLD?

Search